CEO message

Welcome to visit the our website.

We are developing new therapeutics for eye disease to accomplish
our vision, ‘Change your life for the better.'

The KP Biosciences, Inc. was founded from Korea Prime Pharm. Co., LTD. in 2021.
During last 10 years, we have developed and commercialized protein based therapeutics.

KP Biosciences has new inhibitors to various eye diseases.
We have developed interesting pipelines for anti-angiogenesis, anti-fibrosis or anti-inflammation.
KP Biosciences has conducted preclinical studies on various eye-related diseases, such as wet AMD, dry AMD, subretinal fibrosis,
neovascular glaucoma, and etc.

We hope to give novel therapies for patients and their family by supplying highly-effective eye therapeutics.
All members of the KP Biosciences, Inc. promise you to contribute the welfare of human race by supplying a novel therapeutic options
to patients.

Thank you